CIK: 0001792126 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value ($000): $262,899 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 265,600 | $20,236 | 7.7% | $67.19 | 0.0% | COM | 00287Y109 |
| SRPT | SAREPTA THERAPEUTICS INC | 187,350 | $18,327 | 7.0% | $100.93 | +13.3% | COM | 803607100 |
| — | MYOKARDIA INC | 300,000 | $14,064 | 5.3% | $66.90 | — | COM | 62857M105 |
| MRNA | MODERNA INC | 460,000 | $13,777 | 5.2% | $23.01 | 0.0% | COM | 60770K107 |
| ASND | ASCENDIS PHARMA A S | 120,000 | $13,513 | 5.1% | $139.12 | — | SPONSORED ADR | 04351P101 |
| — | REATA PHARMACEUTICALS INC | 82,292 | $11,878 | 4.5% | $185.02 | — | CL A | 75615P103 |
| BMY | BRISTOL-MYERS SQUIBB CO | 194,500 | $10,841 | 4.1% | $48.58 | 0.0% | COM | 110122108 |
| — | ZYMEWORKS INC | 304,417 | $10,798 | 4.1% | $45.46 | — | COM | 98985W102 |
| — | IGM BIOSCIENCES INC | 173,865 | $9,763 | 3.7% | $44.31 | — | COM | 449585108 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 185,933 | $9,499 | 3.6% | $51.09 | — | COM | 37890U108 |
| — | PASSAGE BIO INC | 603,338 | $8,960 | 3.4% | $14.85 | — | COM | 702712100 |
| VRTX | VERTEX PHARMACEUTICALS INC | 33,237 | $7,909 | 3.0% | $229.39 | 0.0% | COM | 92532F100 |
| — | BELLUS HEALTH INC NEW | 775,377 | $7,738 | 2.9% | $8.68 | — | COM NEW | 07987C204 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 247,248 | $7,401 | 2.8% | $23.15 | +14.5% | COM | 462260100 |
| FULC | FULCRUM THERAPEUTICS INC | 532,520 | $6,358 | 2.4% | $14.50 | +10.3% | COM | 359616109 |
| — | 89BIO INC | 247,000 | $6,237 | 2.4% | $25.61 | — | COM | 282559103 |
| — | MOLECULAR TEMPLATES INC | 438,831 | $5,832 | 2.2% | $13.83 | — | COM | 608550109 |
| — | VERASTEM INC | 2,325,582 | $5,526 | 2.1% | $2.38 | — | COM | 92337C104 |
| — | KARUNA THERAPEUTICS INC | 69,658 | $5,015 | 1.9% | $73.90 | — | COM | 48576A100 |
| — | BRISTOL-MYERS SQUIBB CO | 1,275,500 | $4,847 | 1.8% | $3.01 | — | RIGHT 99/99/9999 | 110122157 |
| TXG | 10X GENOMICS INC | 72,831 | $4,539 | 1.7% | $78.04 | 0.0% | CL A COM | 88025U109 |
| CRSP | CRISPR THERAPEUTICS AG | 105,512 | $4,475 | 1.7% | $51.63 | 0.0% | NAMEN AKT | H17182108 |
| — | BLUEPRINT MEDICINES CORP | 75,000 | $4,386 | 1.7% | $58.48 | — | COM | 09627Y109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 39,644 | $4,315 | 1.6% | $115.43 | 0.0% | COM | 02043Q107 |
| FATE | FATE THERAPEUTICS INC | 193,144 | $4,290 | 1.6% | $25.29 | 0.0% | COM | 31189P102 |
| FOLD | AMICUS THERAPEUTICS INC | 446,882 | $4,129 | 1.6% | $9.51 | 0.0% | COM | 03152W109 |
| — | TRILLIUM THERAPEUTICS INC | 995,600 | $4,022 | 1.5% | $4.04 | — | COM NEW | 89620X506 |
| — | LIFESCI ACQUISITION CORP | 400,000 | $3,999 | 1.5% | $10.00 | — | UNIT 03/31/2025 | 53228P208 |
| — | ZOGENIX INC | 152,144 | $3,763 | 1.4% | $52.13 | — | COM NEW | 98978L204 |
| — | IMMUNOMEDICS INC | 276,635 | $3,729 | 1.4% | $13.48 | — | COM | 452907108 |
| — | MIRATI THERAPEUTICS INC | 46,399 | $3,567 | 1.4% | $128.86 | — | COM | 60468T105 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 123,465 | $2,772 | 1.1% | $30.22 | 0.0% | COM | 09203E105 |
| — | SELECTA BIOSCIENCES INC | 1,111,867 | $2,680 | 1.0% | $2.41 | — | COM | 816212104 |
| — | MIRATI THERAPEUTICS INC | 33,300 | $2,560 | 1.0% | $128.86 | — | Call | 60468T105 |
| TGTX | TG THERAPEUTICS INC | 249,844 | $2,458 | 0.9% | $12.63 | 0.0% | COM | 88322Q108 |
| CYTK | CYTOKINETICS INC | 193,129 | $2,277 | 0.9% | $12.76 | 0.0% | COM NEW | 23282W605 |
| — | SAGE THERAPEUTICS INC | 69,591 | $1,999 | 0.8% | $72.19 | — | COM | 78667J108 |
| — | MINERVA NEUROSCIENCES INC | 309,745 | $1,865 | 0.7% | $6.82 | — | COM | 603380106 |
| SVRA | SAVARA INC | 613,999 | $1,172 | 0.4% | $1.20 | +127.8% | COM | 805111101 |
| RVMD | REVOLUTION MEDICINES INC | 53,034 | $1,162 | 0.4% | $27.68 | 0.0% | COM | 76155X100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 15,809 | $221 | 0.1% | $16.70 | +18.6% | COM | 77313F106 |